σ-1 receptors in major depression and anxiety

References

• Martin WR, Eades CG, Thompson JA et al. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther.197(3), 517–532 (1976).
   PubMed Web of Science ®Google Scholar
• Vaupel DB. Naltrexone fails to antagonize the σ effects of PCP and SKF10,047 in the dog. Eur. J. Pharmacol.92(3–4), 269–274 (1983).
   PubMed Web of Science ®Google Scholar
• Quirion R, Chichportiche R, Contreras P et al. Classification and nomenclature of phencyclidine and σ receptor sites. Trends Neurol. Sci.10, 444–446 (1987).
   Web of Science ®Google Scholar
• Bermack JE, Debonnel G. The role of σ receptors in depression. J. Pharmacol. Sci.97(3), 317–336 (2005).
   PubMed Web of Science ®Google Scholar
• Skuza G, Wedzony K. Behavioral pharmacology of σ-ligands. Pharmacopsychiatry37(3), S183–S188 (2004).
   PubMed Web of Science ®Google Scholar
• Su TP, Hayashi T. Understanding the molecular mechanism of σ-1 receptors: towards a hypothesis that σ-1 receptors are intracellular amplifiers for signal transduction. Curr. Med. Chem.10(20), 2073–2080 (2003)
   PubMed Web of Science ®Google Scholar
• Debonnel G. Current hypotheses on σ receptors and their physiological role: possible implications in psychiatry. J. Psychiatry Neurosci.18(4), 157–172 (1993).
   PubMed Web of Science ®Google Scholar
• Hayashi T, Su TP. σ-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival. Cell131(3), 596–610 (2007).
   PubMed Web of Science ®Google Scholar
• Fontanilla D, Johannessen M, Hajipour AR et al. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous σ-1 receptor regulator. Science323(5916), 934–937 (2009).
   PubMed Web of Science ®Google Scholar
• Monnet FP. σ-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance. Biol. Cell97(12), 873–883 (2005).
   PubMed Web of Science ®Google Scholar
• Maurice T, Su TP, Privat A. Sigma1 (σ 1) receptor agonists and neurosteroids attenuate B25–35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience83(2), 413–428 (1998).
   PubMed Web of Science ®Google Scholar
• Matsuno K. Anti-amnesic effects of σ (σ) -receptor agonists. Nippon Yakurigaku Zasshi114(1), 25–33 (1999).
   PubMedGoogle Scholar
• Kamei H, Noda Y, Nabeshima T et al. Effects of σ receptor ligands on psychiatric disorders. Nihon Shinkei Seishin Yakurigaku Zasshi23(5), 187–196 (2003).
   PubMedGoogle Scholar
• Dhir A, Kulkarni SK. Involvement of σ-1 receptor modulation in the antidepressant action of venlafaxine. Neurosci. Lett.420(3), 244–248 (2007).
   Google Scholar
• Noda Y, Kamei H, Nabeshima T. σ-receptor ligands and anti-stress actions. Nippon Yakurigaku Zasshi114(1), 43–49 (1999).
   PubMedGoogle Scholar
• Volz HP, Stoll KD. Clinical trials with σ ligands. Pharmacopsychiatry37(3), S214–S220 (2004).
   PubMed Web of Science ®Google Scholar
• Langa F, Codony X, Tovar V et al. Generation and phenotypic analysis of σ receptor type I (σ 1) knockout mice. Eur. J. Neurosci.18(8), 2188–2196 (2003).
   PubMed Web of Science ®Google Scholar
• Meunier J, Demeilliers B, Célérier A et al. Compensatory effect by σ1 (σ1) receptor stimulation during alcohol withdrawal in mice performing an object recognition task. Behav. Brain Res.166(1), 166–176 (2006).
   PubMed Web of Science ®Google Scholar
• Sheps DS, Sheffield D. Depression, anxiety, and the cardiovascular system: the cardiologist’s perspective. J. Clin. Psychiatry62(8), 12–16 (2001).
   PubMed Web of Science ®Google Scholar
• Rumsfeld JS, Ho PM. Depression and cardiovascular disease: a call for recognition. Circulation111(3), 250–253 (2005).
   PubMed Web of Science ®Google Scholar
• Licinio J, Wong ML. Depression, antidepressants and suicidality: a critical appraisal. Nat. Rev. Drug Discov.4(2), 165–171 (2005).
   PubMed Web of Science ®Google Scholar
• Vijayakumar L. Suicide and mental disorders in Asia. Int. Rev. Psychiatry17(2), 109–114 (2005).
   PubMed Web of Science ®Google Scholar
• Hanner M, Moebius FF, Flandorfer A et al. Purification, molecular cloning, and expression of the mammalian σ1-binding site. Proc. Natl. Acad. Sci. USA93(15), 8072–8077 (1996).
   PubMed Web of Science ®Google Scholar
• Kekuda R, Prasad PD, Fei YJ et al. Cloning and functional expression of the human type 1 σ receptor (hσR1). Biochem. Biophys. Res. Commun.229(2), 553–558 (1996).
   PubMed Web of Science ®Google Scholar
• Seth P, Leibach FH, Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 σ receptor. Biochem. Biophys. Res. Commun.241(2), 535–540 (1997).
   PubMed Web of Science ®Google Scholar
• Seth P, Fei YJ, Li HW et al. Cloning and functional characterization of a σ receptor from rat brain. J. Neurochem.70(3), 922–931 (1998).
   PubMed Web of Science ®Google Scholar
• Leitner ML, Hohmann AG, Patrick SL et al. Regional variation in the ratio of σ 1 to σ 2 binding in rat brain. Eur. J. Pharmacol.259(1), 65–69 (1994).
   PubMed Web of Science ®Google Scholar
• Largent BL, Gundlach AL, Snyder SH. Pharmacological and autoradiographic discrimination of σ and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J. Pharmacol. Exp. Ther.238, 739–748 (1986).
   PubMed Web of Science ®Google Scholar
• Gundlach AL, Largent BL, Snyder SH. Autoradiographic localization of σ receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J. Neurosci.6(6), 1757–1770 (1986).
   PubMed Web of Science ®Google Scholar
• Kitaichi K, Chabot JG, Moebius FF et al. Expression of the purported σ(1) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J. Chem. Neuroanat.20(3–4), 375–387 (2000).
   PubMed Web of Science ®Google Scholar
• Phan VL, Urani A, Sandillon F et al. Preserved σ1 (σ1) receptor expression and behavioral efficacy in the aged C57BL/6 mouse. Neurobiol. Aging24(6), 865–881 (2003).
   PubMed Web of Science ®Google Scholar
• Hayashi T, Maurice T, Su TP. Ca2+ signaling via σ(1)-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration. J. Pharmacol. Exp. Ther.293(3), 788–798 (2000).
   PubMed Web of Science ®Google Scholar
• Hayashi T, Su TP. Regulating ankyrin dynamics: roles of σ-1 receptors. Proc. Natl Acad. Sci. USA98(2), 491–496 (2001).
   PubMed Web of Science ®Google Scholar
• Hong W, Nuwayhid SJ, Werling LL. Modulation of bradykinin-induced calcium changes in SH-SY5Y cells by neurosteroids and σ receptor ligands via a shared mechanism. Synapse54, 102–110 (2004).
   PubMed Web of Science ®Google Scholar
• Urani A, Romieu P, Portales-Casamar E et al. The antidepressant-like effect induced by the σ(1) (σ(1)) receptor agonist igmesine involves modulation of intracellular calcium mobilization. Psychopharmacology (Berl.)163(1), 26–35 (2002).
   PubMed Web of Science ®Google Scholar
• Aydar E, Palmer CP, Klyachko VA et al. The σ receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron34(3), 399–410 (2002).
   PubMed Web of Science ®Google Scholar
• Monnet FP, Debonnel G, Junien JL et al.N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors. Eur. J. Pharmacol.179(3), 441–445 (1990).
   PubMed Web of Science ®Google Scholar
• Martina M, Turcotte ME, Halman σ et al. The σ-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J. Physiol.578(1), 143–157 (2007).
   PubMed Web of Science ®Google Scholar
• Hayashi T, Su T. An update on the development of drugs for neuropsychiatric disorders: focusing on the σ1 receptor ligand. Expert Opin. Ther. Targets12(1), 45–58 (2008).
   PubMed Web of Science ®Google Scholar
• Bergeron R, de Montigny C, Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via σ receptors. J. Neurosci.16(3), 1193–1120 (1996).
   PubMed Web of Science ®Google Scholar
• Nuwayhid SJ, Werling LL. Steroids modulate N-methyl-D-aspartate-stimulated [3H] dopamine release from rat striatum via σ receptors. J. Pharmacol. Exp. Ther.306(3), 934–940 (2003).
   PubMed Web of Science ®Google Scholar
• Collier TL, Waterhouse RN, Kassiou M. Imaging σ receptors: applications in drug development. Curr. Pharm. Des.13(1), 51–72 (2007).
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Ishiwata K. σ receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. Curr. Pharm. Des.12(30), 3857–3876 (2006)
   PubMed Web of Science ®Google Scholar
• Hayashi T, Su TP. σ-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs18(5), 269–284 (2004).
   PubMed Web of Science ®Google Scholar
• Debonnel G, de Montigny C. Modulation of NMDA and dopaminergic neurotransmissions by σ ligands: possible implications for the treatment of psychiatric disorders. Life Sci.58(9), 721–734 (1996).
   PubMed Web of Science ®Google Scholar
• Nabeshima T, Okuyama S. Physiological function of σ receptors: central pharmacological effects of σ ligand. Nihon Shinkei Seishin Yakurigaku Zasshi.14(2), 51–76 (1994).
   PubMedGoogle Scholar
• Levi MS, Brimble MA. A review of neuroprotective agents. Curr. Med. Chem.11(18), 2383–97 (2004).
   PubMed Web of Science ®Google Scholar
• Nakazawa M, Matsuno K, Mita S. Activation of σ1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures. Neurochem. Int.32(4), 337–343 (1998).
   PubMed Web of Science ®Google Scholar
• Bhardwaj A, Sawada M, London ED et al. Potent s1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. Stroke29(11), 2404–2410 (1998)
   PubMed Web of Science ®Google Scholar
• Brammer MK, Gilmore DL, Matsumoto RR. Interactions between 3,4-methylenedioxymethamphetamine and σ1 receptors. Eur. J. Pharmacol.553(1–3), 141–145 (2006).
   PubMed Web of Science ®Google Scholar
• Lysko PG, Gagnon RC, Yue TL et al. Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke23(9), 414–419 (1992).
   PubMed Web of Science ®Google Scholar
• Beltran D, Cavas M, Navarro JF. Effects of (+)SKF 10047, a σ-1 selective agonist, on isolation-induced aggression in male mice. Methods Find. Exp. Clin. Pharmacol.28(9), 601 (2006)
   PubMedGoogle Scholar
• Narita M, Yoshizawa K, Aoki K et al. A putative σ1 receptor antagonist NE-100 attenuates the discriminative stimulus effects of ketamine in rats. Addict. Biol.6(4), 373–376 (2001).
   PubMed Web of Science ®Google Scholar
• Takebayashi M, Hayashi T, Su TP. Nerve growth factor-induced neurite sprouting in PC12 cells involves σ-1 receptors: implications for antidepressants. J. Pharmacol. Exp. Ther.303(3), 1227–1237 (2002).
   PubMed Web of Science ®Google Scholar
• Narita N, Hashimoto K, Tomitaka σ et al. Interactions of selective serotonin reuptake inhibitors with subtypes of σ receptors in rat brain. Eur. J. Pharmacol.307(1), 117–119 (1996).
   PubMed Web of Science ®Google Scholar
• Ishikawa M, Ishiwata K, Ishii K et al. High occupancy of σ-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503. Biol. Psychiatry62(8), 829–946 (2007)
   Google Scholar
• Maurice T, Hiramatsu M, Itoh J et al. Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res.647(1), 44–56 (1994).
   PubMed Web of Science ®Google Scholar
• Bergeron R, de Montigny C, Debonnel G. Biphasic effects of σ ligands on the neuronal response to N-methyl-D-aspartate. Naunyn Schmiedeberg’s Arch. Pharmacol.351(3), 252–260 (1995).
   Google Scholar
• Monnet FP, de Costa BR, Bowen WD. Differentiation of σ ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices. Br. J. Pharmacol.119(1), 65–72 (1996).
   PubMed Web of Science ®Google Scholar
• Dhir A, Kulkarni SK. Involvement of σ (σ1) receptors in modulating the anti-depressant effect of neurosteroids (dehydroepiandrosterone or pregnenolone) in mouse tail-suspension test. J. Psychopharmacol.22(6), 691–696 (2008).
   PubMed Web of Science ®Google Scholar
• Amano M, Yamada K, Matsuno K et al. Neuropharmacological effects of σ receptor ligands: anxiolytic, anti-amnesic and neuroprotective effects. Nihon Shinkei Seishin Yakurigaku Zasshi16(3), 73–84 (1996).
   PubMedGoogle Scholar
• Herrera Y, Katnik C, Rodriguez JD et al. σ-1 receptor modulation of acid-sensing ion channel a (ASIC1a) and ASIC1a-induced Ca2+ influx in rat cortical neurons. J. Pharmacol. Exp. Ther.327(2), 491–502 (2008).
   PubMed Web of Science ®Google Scholar
• Kamei H, Noda Y, Kameyama T et al. Role of (+)-SKF-10,047-sensitive sub-population of σ1 receptors in amelioration of conditioned fear stress in rats: association with mesolimbic dopaminergic systems. Eur. J. Pharmacol.319 (2–3), 165–172 (1997).
   PubMed Web of Science ®Google Scholar
• Sabino V, Cottone P, Parylak SL et al. σ-1 receptor knockout mice display a depressive-like phenotype. Behav. Brain Res.198(2), 472–476 (2009).
   PubMed Web of Science ®Google Scholar
• Skuza G. Potential antidepressant activity of σ ligands. Pol. J. Pharmacol.55(6), 923–934 (2003).
   PubMedGoogle Scholar
• Matsuno K, Kobayashi T, Tanaka M.K et al. σ 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur. J. Pharmacol.312(3), 267–271 (1996).
   PubMed Web of Science ®Google Scholar
• Urani A, Romieu P, Roman FJ et al. Enhanced antidepressant efficacy of σ1 receptor agonists in rats after chronic intracerebroventricular infusion of β-amyloid-(1–40) protein. Eur. J. Pharmacol.486(2), 151–161 (2004).
   PubMed Web of Science ®Google Scholar
• Ukai M, Maeda H, Nanya Y et al. Beneficial effects of acute and repeated administrations of σ receptor agonists on behavioral despair in mice exposed to tail suspension. Pharmacol. Biochem. Behav.61(3), 247–252 (1998).
   PubMed Web of Science ®Google Scholar
• Oshiro Y, Sakurai Y, Sato σ et al. 3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4-dihydro-5-methoxy-2(1H)-quinolinone and its derivatives. J. Med. Chem.43, 177–189 (2000).
   PubMed Web of Science ®Google Scholar
• Reddy DS, Kaur G, Kulkarni SK. σ (σ1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. Neuroreport9(13), 3069–3073 (1998).
   PubMed Web of Science ®Google Scholar
• Chaki S, Nakazato A, Kennis L et al. Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. Eur. J. Pharmacol.485(1–3), 145–158 (2004).
   PubMed Web of Science ®Google Scholar
• Wang J, Mack AL, Coop A et al. Novel σ (σ) receptor agonists produce antidepressant-like effects in mice. Eur. Neuropsychopharmacol.17(11), 708–716 (2007).
   PubMed Web of Science ®Google Scholar
• Phan VL, Miyamoto Y, Nabeshima T et al. Age-related expression of σ1 receptors and antidepressant efficacy of a selective agonist in the senescence-accelerated (SAM) mouse. J. Neurosci. Res.79(4), 561–572 (2005).
   PubMed Web of Science ®Google Scholar
• Takebayashi M, Hayashi T, Su TP. A perspective on the new mechanism of antidepressants: neuritogenesis through σ-1 receptors. Pharmacopsychiatry37(3), S208–S213 (2004).
   PubMed Web of Science ®Google Scholar
• Kikuchi-Utsumi K, Nakaki T. Chronic treatment with a selective ligand for the σ-1 receptor chaperone, SA4503, up-regulates BDNF protein levels in the rat hippocampus. Neurosci. Lett.440(1), 19–22 (2008).
   PubMed Web of Science ®Google Scholar
• Waterhouse RN, Chang RC, Atuehene N et al.In vitro and in vivo binding of neuroactive steroids to the σ-1 receptor as measured with the positron emission tomography radioligand [18F]FPS. Synapse61(7), 540–546 (2007)
   PubMed Web of Science ®Google Scholar
• Horan B, Gifford AN, Matsuno K et al. Effect of SA4503 on the electrically evoked release of (3)H-acetylcholine from striatal and hippocampal rat brain slices. Synapse46(1), 1–3 (2002).
   PubMed Web of Science ®Google Scholar
• Maurice T, Phan VL, Privat A. The anti-amnesic effects of σ1 (σ1) receptor agonists confirmed by in vivo antisense strategy in the mouse. Brain Res.898(1), 113–121 (2001).
   PubMed Web of Science ®Google Scholar
• Maurice T, Junien JL, Privat A. Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via σ 1-receptors. Behav. Brain Res.83(1–2), 159–164 (1997).
   PubMed Web of Science ®Google Scholar
• Gronier B, Debonnel G. Involvement of σ receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems. Eur. J. Pharmacol.368(2–3), 183–196 (1999).
   PubMed Web of Science ®Google Scholar
• Meurs A, Clinckers R, Ebinger G et al. σ 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. Eur. J. Neurosci.26(11), 3079–3092 (2007).
   PubMed Web of Science ®Google Scholar
• Peeters M, Romieu P, Maurice T et al. Involvement of the σ 1 receptor in the modulation of dopaminergic transmission by amantadine. Eur. J. Neurosci.19(8), 2212–2220 (2004).
   PubMed Web of Science ®Google Scholar
• Paquette MA, Brudney EG, Putterman DB et al. σ ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias. Neuroreport19(1), 111–115 (2008).
   PubMed Web of Science ®Google Scholar
• Dong LY, Cheng ZX, Fu YM et al. Neurosteroid dehydroepiandrosterone sulfate enhances spontaneous glutamate release in rat prelimbic cortex through activation of dopamine D1 and σ-1 receptor. Neuropharmacology52(3), 966–974 (2007).
   PubMed Web of Science ®Google Scholar
• Cobos EJ, del Pozo E, Baeyens JM. Irreversible blockade of σ-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells. J. Neurochem.102(3), 812–825 (2007).
   PubMed Web of Science ®Google Scholar
• Inoue A, Sugita S, Shoji H et al. Repeated haloperidol treatment decreases σ(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain. Eur. J. Pharmacol.401(3), 307–316 (2000).
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Matsuno K, Murai M et al. σ 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain. Neurochem. Res.22(9), 105–109 (1997).
   Google Scholar
• Skuza G, Rogoz Z. Antidepressant-like effect of combined treatment with selective σ receptor agonists and a 5-HT1A receptor agonist in the forced swimming test in rats. Pharmacol. Rep.59(6), 773–777 (2007).
   PubMed Web of Science ®Google Scholar
• Reddy DS, Kulkarni SK. Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice. Psychopharmacology (Berl.)128(3), 280–292 (1996).
   PubMed Web of Science ®Google Scholar
• Peyron C, Petit JM, Rampon C et al. Forebrain afferents to the rat dorsal Raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience82(2), 443–468 (1998).
   PubMed Web of Science ®Google Scholar
• Dhir A, Kulkarni SK. Possible involvement of σ-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor. Fundam. Clin. Pharmacol.22(4), 387–394 (2008).
   PubMed Web of Science ®Google Scholar
• Monnet FP, Mahé V, Robel P et al. Neurosteroids, via σ receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl Acad. Sci. USA92(9), 3774–3778 (1995).
   PubMed Web of Science ®Google Scholar
• Skuza G, Rogoz Z. Effect of combined treatment with selective σ ligands and amantadine in the forced swimming test in rats. Pol. J. Pharmacol.54(6), 699–702 (2002).
   PubMedGoogle Scholar
• Skuza G, Rogoz Z. The synergistic effect of selective σ receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats. J. Physiol. Pharmacol.57(2), 217–229 (2006).
   PubMed Web of Science ®Google Scholar
• Nuwayhid SJ, Werling LL. σ1 receptor agonist-mediated regulation of N-methyl-D-aspartate-stimulated [3H]dopamine release is dependent upon protein kinase C. J. Pharmacol. Exp. Ther.304, 364–369 (2003).
   PubMed Web of Science ®Google Scholar
• Kulkarni SK, Dhir A. On the mechanism of antidepressant-like action of berberine chloride. Eur. J. Pharmacol.589(1–3), 163–172 (2008).
   PubMed Web of Science ®Google Scholar
• Dhir A, Kulkarni SK. Antidepressant-like effect of 17β-estradiol: involvement of dopaminergic, serotonergic, and (or) σ-1 receptor systems. Can. J. Physiol. Pharmacol.86, 726–735 (2008).
   PubMed Web of Science ®Google Scholar
• Frieboes RM, Murck H, Wiedemann K et al. Open clinical trial on the σ ligand panamesine in patients with schizophrenia. Psychopharmacology (Berl.)132(1), 82–88 (1997).
   PubMed Web of Science ®Google Scholar
• Pande AC, Geneve J, Scherrer B. Igmesine, a novel σ ligand, has antidepressant properties. Presented at: Congress of Collegium Internationale Neuro-Psychopharmacologicum. 5–10 July, Glasgow, UK 1998.
   Google Scholar
• Hans-Jurgen M, Hans-Peter V, Ingrid RW et al. Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group. J. Clin. Psychopharmacol.21(1), 59–65 (2001).
   PubMed Web of Science ®Google Scholar
• Hirata H, Sonoda S, Agui σ et al. Rubiscolin-6, a δ opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating σ1 and dopamine D1 receptors. Peptides28(10), 1998–2003 (2007).
   PubMed Web of Science ®Google Scholar
• Mamiya T, Noda Y, Noda A et al. Effects of σ receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice. Neuropharmacology39(12), 2391–2398 (2000).
   PubMed Web of Science ®Google Scholar
• Maayan R, Touati-Werner D, Ram E et al. The protective effect of frontal cortex dehydroepiandrosterone in anxiety and depressive models in mice. Pharmacol. Biochem. Behav.85(2), 415–421 (2006).
   PubMed Web of Science ®Google Scholar